Table 2.
Comparison of recently published clinical trials using CD19-targeted CAR-modified T cells
*Data were available for only 1 of 8 patients.
†In the setting of B-ALL patients in complete remission.
Comparison of recently published clinical trials using CD19-targeted CAR-modified T cells
*Data were available for only 1 of 8 patients.
†In the setting of B-ALL patients in complete remission.
